Drug Trial Radar · NCT06963580
Efficacy of MI078 Capsules in Treating Postpartum Depression
Last checked: Nov 19, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Sep 9, 2024
Primary completion
Aug 7, 2025
Study completion Aug 7, 2025
Sponsor
- Lead sponsor
- Nanjing Minova Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a multicenter, randomized, double-blind, placebo-controlled trial. It includes three groups. Each group will enroll 24 participants. The trial aims todetermine: To evaluate the efficacy of MI078 capsules in treating postpartum depression and to explore the optimal dosing regimen for MI078 capsules. To assess the safety of MI078 capsules in postpartum depression patients.
Conditions
- Postpartum Depression
Interventions
MI078 capsule dose 1Drug
MI078 capsule dose 1 for 3 days
MI078 capsule dose 2Drug
MI078 capsule dose 2 for 3 days
placeboDrug
placebo for 3 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in HAM-D17 total scoreTime frame: up to day 31
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
The Affiliated Beijing Anding Hospital of Capital Medical University, Wuhu Hospital
Wuhu, Anhui, China
Beijing HuiLongGuan Hospital
Beijing, Beijing Municipality, China
Xiamen Xian Yue Hospital
Xiamen, Fujian, China
Shunde Hospital of Southern Medical University
Foshan, Guangdong, China
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, China
Guangxi Zhuang Autonomous Region People's Hospital
Nanning, Guangxi, China
The People's Hospital of Guizhou Province
Guiyang, Guizhou, China
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Xingtai People's Hospital
Xingtai, Hebei, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
Shanghai Pudong New Area Mental Health Center
Shanghai, Shanghai Municipality, China
Linfen Central Hospital
Linfen, Shanxi, China
The First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
The First People's Hospital of Hangzhou
Hangzhou, Zhejiang, China
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
The Affiliated Kangning Hospital of Ningbo University
Ningbo, Zhejiang, China
The First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.